Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.47 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25921899 | 1.00 | TRPM8 (0.50) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL2124381 | 0.79 | TRPM8 (0.46) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL2628608 | 0.79 | TRPM8 (0.46) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL28885658 | 0.75 | TRPM8 (0.46) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL20566114 | 0.75 | TRPM8 (0.46) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL19179016 | 0.75 | TRPM8 (0.46) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL27768720 | 0.75 | TRPM8 (0.46) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL27790159 | 0.75 | EPHX1 (0.51) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL30604482 | 0.72 | TRPM8 (0.62) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 | |
| SCHEMBL608359 | 0.71 | TRPM8 (0.56) | TRPM8TRPA1EPHX1KCNA5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3816269-A1 | FRAGRANCE MATERIAL COMPOSITION CONTAINING ?-METHOXYISOBUTYRIC ACID ESTER COMPOUND, AND USE AS FRAGRANCE MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-05-05 | — | — | EP | disclosed |
| US-20170333887-A1 | CATALYSTS FOR METATHESIS REACTIONS INCLUDING ENANTIOSELECTIVE OLEFIN METATHESIS, AND RELATED METHODS | TRUSTEES OF BOSTON COLLEGE | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170333887-A1 | CATALYSTS FOR METATHESIS REACTIONS INCLUDING ENANTIOSELECTIVE OLEFIN METATHESIS, AND RELATED METHODS | SQLE, ICMT, COASY | TRPM8 1083/4885TRPA1 1693/4885EPHX1 574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.